BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 18457957)

  • 1. Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model.
    Derval N; Barandon L; Dufourcq P; Leroux L; Lamazière JM; Daret D; Couffinhal T; Duplàa C
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):248-54. PubMed ID: 18457957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model.
    Barandon L; Couffinhal T; Dufourcq P; Alzieu P; Daret D; Deville C; Duplàa C
    Ann Thorac Surg; 2004 Oct; 78(4):1409-17. PubMed ID: 15464506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
    Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
    J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction.
    Dubois C; Liu X; Claus P; Marsboom G; Pokreisz P; Vandenwijngaert S; Dépelteau H; Streb W; Chaothawee L; Maes F; Gheysens O; Debyser Z; Gillijns H; Pellens M; Vandendriessche T; Chuah M; Collen D; Verbeken E; Belmans A; Van de Werf F; Bogaert J; Janssens S
    J Am Coll Cardiol; 2010 May; 55(20):2232-43. PubMed ID: 20466204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J; Huang Y; Takagawa J; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW; Su H
    J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice: effects on transplanted cell survival and autologous endothelial progenitor cell mobilization.
    Cheng Y; Hu R; Lv L; Ling L; Jiang S
    J Surg Res; 2012 Jul; 176(1):e47-55. PubMed ID: 22595018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction.
    Shyu KG; Wang BW; Hung HF; Chang CC; Shih DT
    J Biomed Sci; 2006 Jan; 13(1):47-58. PubMed ID: 16283432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.
    Boomsma RA; Swaminathan PD; Geenen DL
    Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.
    Hu X; Wang J; Chen J; Luo R; He A; Xie X; Li J
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):438-43. PubMed ID: 17239611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction.
    Sun L; Cui M; Wang Z; Feng X; Mao J; Chen P; Kangtao M; Chen F; Zhou C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):779-84. PubMed ID: 17445769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining erythropoietin infusion with intramyocardial delivery of bone marrow cells is more effective for cardiac repair.
    Zhang D; Zhang F; Zhang Y; Gao X; Li C; Yang N; Cao K
    Transpl Int; 2007 Feb; 20(2):174-83. PubMed ID: 17239026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model.
    Wei HJ; Chen SC; Chang Y; Hwang SM; Lin WW; Lai PH; Chiang HK; Hsu LF; Yang HH; Sung HW
    Biomaterials; 2006 Nov; 27(31):5409-19. PubMed ID: 16844214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.
    Dai W; Hale SL; Martin BJ; Kuang JQ; Dow JS; Wold LE; Kloner RA
    Circulation; 2005 Jul; 112(2):214-23. PubMed ID: 15998673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.
    Wang Y; Haider HK; Ahmad N; Xu M; Ge R; Ashraf M
    J Mol Cell Cardiol; 2006 May; 40(5):736-45. PubMed ID: 16603183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor.
    Fazel S; Chen L; Weisel RD; Angoulvant D; Seneviratne C; Fazel A; Cheung P; Lam J; Fedak PW; Yau TM; Li RK
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1310. PubMed ID: 16256783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells.
    Schmeckpeper J; Ikeda Y; Kumar AH; Metharom P; Russell SJ; Caplice NM
    Differentiation; 2009; 78(2-3):169-76. PubMed ID: 19715661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation.
    Noiseux N; Gnecchi M; Lopez-Ilasaca M; Zhang L; Solomon SD; Deb A; Dzau VJ; Pratt RE
    Mol Ther; 2006 Dec; 14(6):840-50. PubMed ID: 16965940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
    Li W; Ma N; Ong LL; Nesselmann C; Klopsch C; Ladilov Y; Furlani D; Piechaczek C; Moebius JM; Lützow K; Lendlein A; Stamm C; Li RK; Steinhoff G
    Stem Cells; 2007 Aug; 25(8):2118-27. PubMed ID: 17478584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
    Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
    Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.